| Literature DB >> 29958798 |
Jialie Luo1, Aihua Qian2, Landon K Oetjen3, Weihua Yu4, Pu Yang1, Jing Feng1, Zili Xie1, Shenbin Liu1, Shijin Yin5, Dari Dryn6, Jizhong Cheng7, Terrence E Riehl8, Alexander V Zholos6, William F Stenson8, Brian S Kim9, Hongzhen Hu10.
Abstract
Intestinal macrophages are critical for gastrointestinal (GI) homeostasis, but our understanding of their role in regulating intestinal motility is incomplete. Here, we report that CX3C chemokine receptor 1-expressing muscularis macrophages (MMs) were required to maintain normal GI motility. MMs expressed the transient receptor potential vanilloid 4 (TRPV4) channel, which senses thermal, mechanical, and chemical cues. Selective pharmacologic inhibition of TRPV4 or conditional deletion of TRPV4 from macrophages decreased intestinal motility and was sufficient to reverse the GI hypermotility that is associated with chemotherapy treatment. Mechanistically, stimulation of MMs via TRPV4 promoted the release of prostaglandin E2 and elicited colon contraction in a paracrine manner via prostaglandin E receptor signaling in intestinal smooth muscle cells without input from the enteric nervous system. Collectively, our data identify TRPV4-expressing MMs as an essential component required for maintaining normal GI motility and provide potential drug targets for GI motility disorders.Entities:
Keywords: COX-1; CX3CR1; E-prostanoid receptor; TRPV4; chemogenetics; gastrointestinal motility; muscularis macrophage; optogenetics; prostaglandin E2
Mesh:
Substances:
Year: 2018 PMID: 29958798 PMCID: PMC6051912 DOI: 10.1016/j.immuni.2018.04.021
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745